Hormones and other variables make a difference in how potential therapeutics behave, and both males and females must be accounted for in trials to move medical advances forward, researchers said.
"Right now, when you go to the doctor and you are given a prescription, it might not ever have been specifically tested in females," said Deborah J Clegg from Cedars-Sinai Hospital in the US.
"Almost all basic research - regardless of whether it involves rodent models, dogs, or humans - is predominately done in males. The majority of research is done with the assumption that men and women are biologically the same," said Clegg.
Often overlooked in male-only studies, these sex hormones are implicated in all biological processes, including sensitivity to fatty acids, or the ability to metabolise simple sugars, she said.
These differences have implications for all clinical trials, whether they are testing the effects of a drug or a body's ability to tolerate an organ transplant.
There is little research examining whether drugs behave differently in the presence of an XX chromosome as opposed to an XY chromosome.
Even genome-wide studies often do not take chromosomes into account, even though sex chromosomes are an integral piece of an individual's genomic makeup.
"It would be great if there were drugs that were specifically tested and dosed based on sex," said Clegg.
"With the goal of personalised medicine, it is important to begin to address and focus on sex as a biological variable," she said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
